| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1954) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N03AA03 |
| UNII: | 13AFD7670Q |
| InChI Key | DQMZLTXERSFNPB-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C12H14N2O2 |
| Molecular Weight | 218.26 |
| AlogP | 0.54 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 58.2 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 16.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | 13 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 78 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Stroke | 2 | D020521 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 125-33-7 |
| ChEBI | 8412 |
| ChEMBL | CHEMBL856 |
| DrugBank | DB00794 |
| DrugCentral | 2267 |
| EPA CompTox | DTXSID7023510 |
| FDA SRS | 13AFD7670Q |
| Human Metabolome Database | HMDB0014932 |
| Guide to Pharmacology | 5338 |
| KEGG | C07371 |
| PharmGKB | PA451105 |
| PubChem | 4909 |
| SureChEMBL | SCHEMBL34221 |
| ZINC | ZINC000000001979 |